Ordering
Available Variants10 mg
CHA.75947-10mg
Price
€72.16
Available – Dispatch in 14 days
50 mg
CHA.75947-50mg
Price
€292.00
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
10 mg | CHA.75947-10mg | €72.16 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
50 mg | CHA.75947-50mg | €292.00 |
≥95% (HPLC), powder, PDE inhibitor
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C24H31NO4 · HCl |
|---|---|
| CAS Number | 985-12-6 |
| Molecular Weight | 433.97 |
| NACRES | NA.77 |
| UNSPSC Code | 12352200 |
| MDL number | MFCD00347721 |
| Assay | ≥95% (HPLC) |
| Form | powder |
| Quality level | 100 |
| Storage condition | desiccated |
Safety Information Handling visibility
| pictograms |
GHS07
 GHS07
|
|---|---|
| signalword | Warning |
| hcodes | H302 |
| pcodes | P264 - P270 - P301 + P312 - P501 |
| Hazard Classifications | Acute Tox. 4 Oral |
| Storage Class | 11 - Combustible Solids |
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
Drotaverine hydrochloride, with a chemical formula of C20H31NO3 and a CAS number of 985-12-6, is a pharmaceutical compound that functions as an antispasmodic agent. It is primarily used to relieve smooth muscle spasms, particularly in the gastrointestinal tract, and is often prescribed for the treatment of irritable bowel syndrome and other gastrointestinal disorders. The mechanism of action of drotaverine hydrochloride involves the inhibition of phosphodiesterase 4, which leads to an increase in cyclic adenosine monophosphate levels, resulting in smooth muscle relaxation. This compound has been shown to be effective in reducing the frequency and severity of abdominal pain and other symptoms associated with gastrointestinal disorders, and is generally well-tolerated with minimal side effects. Drotaverine hydrochloride is available in various formulations, including tablets and injections, and is widely used in clinical practice.
